Musculoskeletal Disorders in Mountain Runners

February 8, 2019 updated by: Paolo Pillastrini, University of Bologna

Prevalence of Musculoskeletal Disorders in Mountain Runners

the study aims to estimate the prevalence of musculoskeletal disorders in a population of runners in the mountains; moreover it proposes to explore the relationship between distance traveled, the difference in height, the training frequency in the week, the shoes worn, the training method, the use of supports and experience of running with musculoskeletal disorders. The secondary objectives of this study are to investigate to which rehabilitative figures the sportsman turns and if the treatments have positive outcomes.

Study Overview

Detailed Description

Running is one of the most popular forms of exercise in the world. The prevalence of musculoskeletal disorders in street runners has already been extensively studied and is about 55% of those affected. In recent years, more and more runners paid their attention to mountain running where, the different types of terrain and the important differences in height require a different musculoskeletal effort. In the literature there are few studies that have investigated the prevalence of disorders, risk factors and protective factors on these runners. The mountain running performed with regularity and method is certainly a healthy activity for individuals, but it is not free from injuries due to several factors, such as long distance, significant differences in level and uneven terrain. It is not clear whether these factors can influence the onset of skeletal muscle disorders. The study aims to estimate the prevalence of musculoskeletal disorders in this population of mountain runners; moreover it proposes to explore in this population the relationship between distance traveled, the difference in height, the training frequency in the week, the shoes worn, the training method, the use of supports and experience of running with musculoskeletal disorders. Moreover, the study wants to investigate to which rehabilitative figures the sportsman turns and if the treatments have positive outcomes. Inclusion criteria are: age over 18, be a participant of at least one trail, understand the Italian language, to have signed informed consent. Recruitment: all participants in mountain races will be invited to reply to the attached questionnaire anonymously when the race bib is picked up. The runners will be free to participate or not in the survey, without the choice can affect the results of the race in any way and can create situations of subjection to the organization.

Study Type

Observational

Enrollment (Actual)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Emilia-Romagna
      • Bologna, Emilia-Romagna, Italy, 40138
        • University of Bologna

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

mountain runners participating in competitions over the age of 18

Description

Inclusion Criteria:

  • age over 18,
  • be a participant of at least one mountain race
  • understand the Italian language
  • have signed an informed consent

Exclusion Criteria:

  • under the age of 18
  • do not understand Italian language
  • not having given consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
presence of musculoskeletal disorders
Time Frame: through study completion, an average of 6 months
this outcome is self-reported
through study completion, an average of 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Paolo Pillastrini, Bologna University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 30, 2018

Primary Completion (Actual)

January 20, 2019

Study Completion (Actual)

January 30, 2019

Study Registration Dates

First Submitted

August 12, 2018

First Submitted That Met QC Criteria

August 15, 2018

First Posted (Actual)

August 17, 2018

Study Record Updates

Last Update Posted (Actual)

February 11, 2019

Last Update Submitted That Met QC Criteria

February 8, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 07082018

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Diseases

Clinical Trials on Questionnaire administration to gather information

3
Subscribe